Datavant Raises $40 Million in Series B Financing to Expand Open Health Data Ecosystem
BioSpace
Datavant, the leader in helping life sciences and healthcare organizations safely connect their data while protecting patient privacy, today announced $40 million in Series B funding, bringing Datavant's cumulative fundraising to $83 million. The round was led by Transformation Capital, with participation by new investors Johnson & Johnson Innovation - JJDC, Inc. and Cigna Ventures, as well as participation by existing shareholders Roivant Sciences and Flex Capital. This investment will support Datavant as it continues to expand the open healthcare data ecosystem and reduce the friction in the exchange and linking of healthcare data.
"Datavant's mission is to connect the world's health data to improve patient outcomes. The fragmentation of health data across...